EUVIMEDEUVIMED entdecken
Crossref

Optimal therapy schedule of chimeric antigen receptor (CAR) T cell immunotherapy

Ruohan Li, Jinzhi Lei

Mathematical Biosciences and Engineering · 2025

DOI: 10.3934/mbe.2025061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mathematical Biosciences and Engineering, 2025. Verfasst von Ruohan Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematical Sciences, Tiangong University, Tianjin 300387, China. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, T-Lymphocytes, Neoplasms. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenImmunotherapy, AdoptiveT-LymphocytesNeoplasmsHumansComputer SimulationTumor MicroenvironmentAntigens, CD19Receptors, Antigen, T-CellTreatment OutcomeImmunotherapyModels, Immunological

Stichwörter der Autor:innen

B-ALLCAR-T therapymathematical modeloptimal therapytumor-immune microenvironment

Substanzen

Receptors, Chimeric AntigenAntigens, CD19Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • School of Mathematical Sciences, Tiangong University, Tianjin 300387, China.
  • Center for Applied Mathematics, Tiangong University, Tianjin 300387, China.

Zitieren

APA

Li, R., & Lei, J. (2025). Optimal therapy schedule of chimeric antigen receptor (CAR) T cell immunotherapy. Mathematical Biosciences and Engineering. https://doi.org/10.3934/mbe.2025061

Vancouver

Li R, Lei J. Optimal therapy schedule of chimeric antigen receptor (CAR) T cell immunotherapy. Mathematical Biosciences and Engineering. 2025. doi:10.3934/mbe.2025061

BibTeX
@article{Li2025,
  author = {Li, Ruohan and Lei, Jinzhi},
  title = {Optimal therapy schedule of chimeric antigen receptor (CAR) T cell immunotherapy},
  journal = {Mathematical Biosciences and Engineering},
  year = {2025},
  doi = {10.3934/mbe.2025061}
}
Kostenlos starten →